Williams Jones & Associates’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q2 | $67.8M | Buy |
230,915
+9,136
| +4% | +$2.68M | 1.41% | 24 |
|
|
2019
Q1 | $60.7M | Buy |
221,779
+20,993
| +10% | +$5.75M | 1.34% | 26 |
|
|
2018
Q4 | $44.9M | Sell |
200,786
-6,666
| -3% | -$1.49M | 1.22% | 26 |
|
|
2018
Q3 | $50.6M | Buy |
207,452
+1,399
| +0.7% | +$341K | 1.02% | 35 |
|
|
2018
Q2 | $42.7M | Buy |
206,053
+11,413
| +6% | +$2.36M | 0.94% | 41 |
|
|
2018
Q1 | $40.2M | Buy |
194,640
+5,487
| +3% | +$1.13M | 0.93% | 42 |
|
|
2017
Q4 | $35.9M | Buy |
189,153
+38,223
| +25% | +$7.26M | 0.82% | 43 |
|
|
2017
Q3 | $28.6M | Buy |
150,930
+3,021
| +2% | +$572K | 0.7% | 46 |
|
|
2017
Q2 | $25.8M | Buy |
147,909
+12,957
| +10% | +$2.26M | 0.65% | 46 |
|
|
2017
Q1 | $20.7M | Buy |
134,952
+5,684
| +4% | +$873K | 0.54% | 52 |
|
|
2016
Q4 | $18.2M | Buy |
129,268
+10,398
| +9% | +$1.47M | 0.52% | 53 |
|
|
2016
Q3 | $18.9M | Sell |
118,870
-1,666
| -1% | -$265K | 0.55% | 59 |
|
|
2016
Q2 | $17.8M | Buy |
120,536
+3,515
| +3% | +$519K | 0.55% | 59 |
|
|
2016
Q1 | $16.6M | Buy |
117,021
+13,603
| +13% | +$1.93M | 0.77% | 42 |
|
|
2015
Q4 | $14.7M | Buy |
103,418
+86,006
| +494% | +$12.2M | 0.67% | 45 |
|
|
2015
Q3 | $2.13M | Buy |
17,412
+3,400
| +24% | +$416K | 0.1% | 137 |
|
|
2015
Q2 | $1.82M | Buy |
14,012
+905
| +7% | +$117K | 0.07% | 159 |
|
|
2015
Q1 | $1.76M | Buy |
13,107
+4,335
| +49% | +$582K | 0.07% | 164 |
|
|
2014
Q4 | $1.1M | Buy |
8,772
+321
| +4% | +$40.2K | 0.05% | 185 |
|
|
2014
Q3 | $1.03M | Sell |
8,451
-871
| -9% | -$106K | 0.05% | 167 |
|
|
2014
Q2 | $1.1M | Sell |
9,322
-4,722
| -34% | -$557K | 0.05% | 159 |
|
|
2014
Q1 | $1.69M | Buy |
14,044
+7,722
| +122% | +$929K | 0.03% | 200 |
|
|
2013
Q4 | $704K | Buy |
6,322
+2,150
| +52% | +$239K | 0.03% | 174 |
|
|
2013
Q3 | $384K | Buy |
4,172
+572
| +16% | +$52.6K | 0.02% | 209 |
|
|
2013
Q2 | $305K | Buy |
+3,600
| New | +$305K | 0.02% | 262 |
|